PAR 0.00% 22.0¢ paradigm biopharmaceuticals limited..

Not necessarily this calendar year. MPS VI read out not until...

  1. 588 Posts.
    lightbulb Created with Sketch. 134
    Not necessarily this calendar year. MPS VI read out not until November and then PAR will speak to authorities to see if Phase 3 needed. If P3 not needed then asset becomes more valuable. If P3 needed then any upfront payments likely to be used for P3 trials in MPS as per 28 April announcement. So imo MPS deal likely first half of next year but doesn't take away need for capital. Someone mentioned previously needing at least another $100mn to finish KOA trials which I scoffed at. Looking at all the trials in 2024, they could well be right. I'm hoping I'm wrong, but I don't see where we get funding pre 2024 without a capital raise.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $76.95M
Open High Low Value Volume
22.0¢ 23.5¢ 22.0¢ $66.95K 294.6K

Buyers (Bids)

No. Vol. Price($)
8 90092 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 25858 1
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.